Page last updated: 2024-11-12
4-nitrophenyl maltopentaoside
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
4-nitrophenyl maltopentaoside: RN given is for all alpha sugars [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 71300873 |
MeSH ID | M0203147 |
Synonyms (6)
Synonym |
---|
4-nitrophenyl maltopentaoside |
p-nitrophenyl alpha-maltopentaoside |
alpha-d-glucopyranoside, 4-nitrophenyl o-alpha-d-glucopyranosyl-(1-4)-o-alpha-d-glucopyranosyl-(1-4)-o-alpha-d-glucopyranosyl-(1-4)-o-alpha-d-glucopyranosyl-(1-4)- |
4-nitrophenyl alpha-d-maltopentaoside |
p-nitrophenyl alpha-d-maltopentaoside |
DTXSID40216269 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |